Stay updated on Tildrakizumab for Chronic Plaque Psoriasis Clinical Trial

Sign up to get notified when there's something new on the Tildrakizumab for Chronic Plaque Psoriasis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tildrakizumab for Chronic Plaque Psoriasis Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Study design, interventions, outcomes, eligibility criteria, and dates appear unchanged compared with the previous version. No new content or deletions affecting the core information on the Study Details page were detected.
    Difference
    0.3%
    Check dated 2025-11-03T11:39:47.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    42 days ago
    Change Detected
    Summary
    - Updated operating-status notice and new version tag (v3.2.0) added; old version tag (v3.1.0) removed. The page now provides current status guidance and a newer software/document version.
    Difference
    1%
    Check dated 2025-10-05T16:43:31.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    Page revision updated from v3.0.2 to v3.1.0, indicating a version bump with no other substantive content changes.
    Difference
    0.0%
    Check dated 2025-09-28T10:05:56.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Updated the page from Revision: v3.0.1 to Revision: v3.0.2. The 'Back to Top' element was removed, a minor UI change.
    Difference
    0.1%
    Check dated 2025-09-14T00:18:28.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    The page has updated the publication date and version number of a study on tildrakizumab's efficacy and safety in psoriasis patients.
    Difference
    0.2%
    Check dated 2025-09-06T21:10:02.000Z thumbnail image
  8. Check
    78 days ago
    Change Detected
    Summary
    The web page has been updated to include new drug information for Tildrakizumab and a new facility name and location, while removing several previous location details and drug information for Etanercept.
    Difference
    3%
    Check dated 2025-08-30T15:37:27.000Z thumbnail image

Stay in the know with updates to Tildrakizumab for Chronic Plaque Psoriasis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tildrakizumab for Chronic Plaque Psoriasis Clinical Trial page.